Trademark applications and grants for Kringle Pharma Inc. Kringle Pharma Inc has 12 trademark applications. The latest application filed is for "KPIRSLA"
Patent Application | Date |
---|---|
HGF PREPARATION SUITABLE FOR TREATMENT OF NEUROLOGICAL DISORDERS 20190117732 - 16/235132 FUKUTA; Kazuhiro ;   et al. | 2019-04-25 |
HGF PREPARATION SUITABLE FOR TREATMENT OF NEUROLOGICAL DISORDERS 20170333527 - 15/507886 FUKUTA; Kazuhiro ;   et al. | 2017-11-23 |
THERAPEUTIC AGENT FOR CANCER HAVING REDUCED SENSITIVITY TO MOLECULAR TARGET DRUG AND PHARMACEUTICAL COMPOSITION FOR ENHANCING SENSITIVITY TO MOLECULAR TARGET DRUG 20140056910 - 14/057398 YANO; Seiji ;   et al. | 2014-02-27 |
THERAPEUTIC AGENT FOR CANCER HAVING REDUCED SENSITIVITY TO MOLECULAR TARGET DRUG AND PHARMACEUTICAL COMPOSITION FOR ENHANCING SENSITIVITY TO MOLECULAR TARGET DRUG 20120064090 - 13/258718 Yano; Seiji ;   et al. | 2012-03-15 |
PROMOTER FOR REGENERATION OF TENDON-BONE JUNCTION TISSUE OR LIGAMENT-BONE JUNCTION TISSUE 20110312887 - 13/123091 Tomita; Katsuro ;   et al. | 2011-12-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.